Physician
Apple Urgent Care, INC
Apple Urgent Care, INC was paid $20.29M by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 47% of everything it billed.
33Billing provider infoAPPLE URGENT CARE, INC
HEMET, CA 92543
HEMET, CA 92543
33aNPI1316005572assigned 12/04/2006
33bProvider typeFamily Medicine Physician
28Total paid$20.29M
24GClaims563,037
24DCodes billed50
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in California
Rank by total paid#24 of 2,511
Median peer was paid$13K
This provider vs. median1,580×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 43,982 | $2.33M | |
| 2019 | 53,878 | $1.99M | |
| 2020 | 39,721 | $1.31M | |
| 2021 | 68,025 | $2.10M | |
| 2022 | 82,622 | $2.62M | |
| 2023 | 134,743 | $4.69M | |
| 2024incomplete | 140,066 | $5.24M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 47% | 248,779 | 232,637 | $9.56M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 35% | 119,846 | 119,208 | $7.05M |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 14% | 44,249 | 40,841 | $2.85M |
| S9083 | Global fee urgent care centers | 1.1% | 12,877 | 11,771 | $225K |
| 0001A | <1% | 3,942 | 3,858 | $143K | |
| 0002A | <1% | 3,630 | 3,591 | $139K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 5,502 | 5,274 | $92K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 3,653 | 3,406 | $48K |
| 0004A | <1% | 915 | 912 | $36K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 19,812 | 18,164 | $30K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 15,747 | 14,174 | $20K |
| 0071A | <1% | 461 | 461 | $18K |
38 more codes
| 0072A | <1% | 433 | $17K | |
| 81002 | <1% | 35,032 | $7K | |
| 87800 | <1% | 5,113 | $7K | |
| 0012A | <1% | 162 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 4,283 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 4,543 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,894 | $4K |
| 87428 | <1% | 1,607 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,549 | $3K |
| 0011A | <1% | 193 | $3K | |
| 0003A | <1% | 87 | $3K | |
| 93000 | <1% | 1,317 | $3K | |
| 69210 | <1% | 2,157 | $3K | |
| 81025 | <1% | 4,265 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,424 | $1K |
| 82962 | <1% | 2,683 | $1K | |
| 85018 | <1% | 1,470 | $689.83 | |
| 99070 | <1% | 1,124 | $540.82 | |
| 99000 | <1% | 487 | $352.97 | |
| 90714 | <1% | 86 | $251.04 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 538 | $166.96 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 400 | $117.15 |
| 99205 | Prolong outpt/office vis | <1% | 210 | $81.87 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 29 | $68.73 |
| 92081 | <1% | 49 | $60.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 88 | $51.06 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,355 | $43.85 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 647 | $24.47 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 263 | $0.00 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 327 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 840 | $0.00 |
| 99382 | 0% | 53 | $0.00 | |
| 10060 | 0% | 12 | $0.00 | |
| 99383 | 0% | 317 | $0.00 | |
| 99384 | 0% | 328 | $0.00 | |
| 99385 | 0% | 136 | $0.00 | |
| 88141 | 0% | 111 | $0.00 | |
| 65205 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialREDDY, SURYA (PRESIDENT OWNER)